Takeda chief woos top Shire in­vestors over £35bn deal

The Daily Telegraph - Business - - Business - By Iain With­ers and Tom Rees

THE chief of the Ja­panese phar­ma­ceu­ti­cal gi­ant cir­cling FTSE 100 drug­maker Shire is to fly to the US this week as part of an in­ter­na­tional charm of­fen­sive to per­suade in­vestors to back a £35bn takeover bid for its UK ri­val.

Christophe We­ber, the French boss of Takeda, is un­der­stood to be lin­ing up meet­ings with its ma­jor share­hold­ers ahead of mak­ing a po­ten­tial of­fer for Shire. Its top five in­vestors in­clude US-based Black­rock, Cap­i­tal Group and JP Mor­gan. City sources told The

Daily Tele­graph that Takeda was un­der­stood to be con­sid­er­ing split­ting Shire and sell­ing its neu­ro­science divi­sion in or­der to help fi­nance the deal.

Con­cerns have been raised by an­a­lysts that Takeda will strug­gle to fund the takeover.

An­a­lysts said sell­ing Shire’s neu­ro­science divi­sion – in­clud­ing its lu­cra­tive port­fo­lio of ADHD drugs – may make sense as the two com­pa­nies’ units were fo­cused in dif­fer­ent ar­eas. Takeda would be left with Shire’s larger and higher mar­gin rare dis­eases busi­ness.

Takeda de­clined to com­ment.

Newspapers in English

Newspapers from UK

© PressReader. All rights reserved.